J Capellades1, P Teixidor2, G Villalba3, C Hostalot2, G Plans4, R Armengol2, S Medrano1, A Estival5, R Luque6, S Gonzalez1, M Gil-Gil7, S Villa8, J Sepulveda9, J J García-Mosquera5, C Balana10. 1. Neuro-radiology Service, Hospital del Mar, 08003, Barcelona, Spain. 2. Neurosurgery Service, Hospital Universitari Germans Trias i Pujol, IGTP, 08916, Badalona, Spain. 3. Neurosurgery Service, Hospital del Mar, 08003, Barcelona, Spain. 4. Neurosurgery Service, Hospital de Bellvitge, IDIBELL, L'Hospitalet de Llobregat, 08907, Barcelona, Spain. 5. Medical Oncology Service, Institut Catala d'Oncologia, Hospital Universitari Germans Trias i Pujol, IGTP, Ctra Canyet, s/n, 08916, Badalona, Spain. 6. Medical Oncology Service, Hospital Universitario Virgen de las Nieves, 18014, Granada, Spain. 7. Medical Oncology Service, Institut Catala d'Oncologia, Hospital Duran i Reynals, IDIBELL, L'Hospitalet de Llobregat, 08908, Barcelona, Spain. 8. Radiation Oncology Service, Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol, IGTP, 08916, Badalona, Spain. 9. Medical Oncology Service, Hospital Universitario 12 de Octubre, 28041, Madrid, Spain. 10. Medical Oncology Service, Institut Catala d'Oncologia, Hospital Universitari Germans Trias i Pujol, IGTP, Ctra Canyet, s/n, 08916, Badalona, Spain. cbalana@iconcologia.net.
Abstract
PURPOSE: We assessed agreement among neurosurgeons on surgical approaches to individual glioblastoma patients and between their approach and those recommended by the topographical staging system described by Shinoda. METHODS: Five neurosurgeons were provided with pre-surgical MRIs of 76 patients. They selected the surgical approach [biopsy, partial resection, or gross total resection (GTR)] that they would recommend for each patient. They were blinded to each other's response and they were told that patients were younger than 50 years old and without symptoms. Three neuroradiologists classified each case according to the Shinoda staging system. RESULTS: Biopsy was recommended in 35.5-82.9%, partial resection in 6.6-32.9%, and GTR in 3.9-31.6% of cases. Agreement among their responses was fair (global kappa = 0.28). Nineteen patients were classified as stage I, 14 as stage II, and 43 as stage III. Agreement between the neurosurgeons and the recommendations of the staging system was poor for stage I (kappa = 0.14) and stage II (kappa = 0.02) and fair for stage III patients (kappa = 0.29). An individual analysis revealed that in contrast to the Shinoda system, neurosurgeons took into account T2/FLAIR sequences and gave greater weight to the involvement of eloquent areas. CONCLUSIONS: The surgical approach to glioblastoma is highly variable. A staging system could be used to examine the impact of extent of resection, monitor post-operative complications, and stratify patients in clinical trials. Our findings suggest that the Shinoda staging system could be improved by including T2/FLAIR sequences and a more adequate weighting of eloquent areas.
PURPOSE: We assessed agreement among neurosurgeons on surgical approaches to individual glioblastomapatients and between their approach and those recommended by the topographical staging system described by Shinoda. METHODS: Five neurosurgeons were provided with pre-surgical MRIs of 76 patients. They selected the surgical approach [biopsy, partial resection, or gross total resection (GTR)] that they would recommend for each patient. They were blinded to each other's response and they were told that patients were younger than 50 years old and without symptoms. Three neuroradiologists classified each case according to the Shinoda staging system. RESULTS: Biopsy was recommended in 35.5-82.9%, partial resection in 6.6-32.9%, and GTR in 3.9-31.6% of cases. Agreement among their responses was fair (global kappa = 0.28). Nineteen patients were classified as stage I, 14 as stage II, and 43 as stage III. Agreement between the neurosurgeons and the recommendations of the staging system was poor for stage I (kappa = 0.14) and stage II (kappa = 0.02) and fair for stage III patients (kappa = 0.29). An individual analysis revealed that in contrast to the Shinoda system, neurosurgeons took into account T2/FLAIR sequences and gave greater weight to the involvement of eloquent areas. CONCLUSIONS: The surgical approach to glioblastoma is highly variable. A staging system could be used to examine the impact of extent of resection, monitor post-operative complications, and stratify patients in clinical trials. Our findings suggest that the Shinoda staging system could be improved by including T2/FLAIR sequences and a more adequate weighting of eloquent areas.
Entities:
Keywords:
Glioblastoma; Intention; Inter-observer variability; Radicality; Staging; Surgery
Authors: Mark E Oppenlander; Andrew B Wolf; Laura A Snyder; Robert Bina; Jeffrey R Wilson; Stephen W Coons; Lynn S Ashby; David Brachman; Peter Nakaji; Randall W Porter; Kris A Smith; Robert F Spetzler; Nader Sanai Journal: J Neurosurg Date: 2014-01-31 Impact factor: 5.115
Authors: Philip C De Witt Hamer; Santiago Gil Robles; Aeilko H Zwinderman; Hugues Duffau; Mitchel S Berger Journal: J Clin Oncol Date: 2012-04-23 Impact factor: 44.544
Authors: Matthew J McGirt; Debraj Mukherjee; Kaisorn L Chaichana; Khoi D Than; Jon D Weingart; Alfredo Quinones-Hinojosa Journal: Neurosurgery Date: 2009-09 Impact factor: 4.654
Authors: Even Hovig Fyllingen; Lars Eirik Bø; Ingerid Reinertsen; Asgeir Store Jakola; Lisa Millgård Sagberg; Erik Magnus Berntsen; Øyvind Salvesen; Ole Solheim Journal: Acta Neurochir (Wien) Date: 2021-03-20 Impact factor: 2.216